US Patent Issued to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG on July 7 for "Valiolamine derivatives as glucosidase inhibitors" (Maryland Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,924, issued on July 7, was assigned to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (Gaithersburg, Md.).

"Valiolamine derivatives as glucosidase inhibitors" was invented by Anthony M. Treston (Gaithersburg, Md.) and Kelly Lyn Warfield (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is directed to N-substituted valiolamine compounds, their use as glycosidase inhibitors, and in methods of treating diseases or conditions in which glycosidase inhibition provides benefit."

The patent was filed on March 2, 2022, under Application No. 18/279,920.

*For further information, including images, charts and tables, please visi...